Performance-Conditioned Stock Acquisition Rights as an Incentive for Directors and Employees
First written in FY2017-Q2. 7 of 10 entries say "Advanced", first in FY2018-Q1. Latest entry: FY2026.
The whole theme swung hardest in 2020: 2 of 16 companies on the "Worse" side.
11 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「Exercised 3,288,000 Expired 52,500 Remaining unexercised 108,538,500」
Of the performance-based stock acquisition rights, rights equivalent to 3,288,000 shares were exercised during the period and rights equivalent to 52,500 shares expired, leaving 108,538,500 shares equivalent unexercised. - FY2025AdvancedAnnual report
「After vesting (shares): balance at end of previous consolidated fiscal year 7,628,100; exercised 161,000; expired 8,500; remaining unexercised 7,458,600」
Of the performance-based stock acquisition rights, 161,000 shares were exercised and 8,500 shares expired, leaving 7,458,600 shares unexercised. - FY2025-H1AdvancedAnnual report
「1 April 2024 to 30 September 2024: 148,500 shares; change in stated capital: ¥195 million; change in capital surplus: ¥195 million. (Note) Increase resulting from the exercise of stock acquisition rights.」
The exercise of performance-based stock acquisition rights resulted in the issuance of 148,500 shares, increasing stated capital and capital surplus by ¥195 million each. - FY2024AdvancedAnnual report
「Exercised 383,800; expired 5,800; remaining unexercised 7,628,100」
Of the stock acquisition rights subject to EBITDA targets, rights equivalent to 383,800 shares were exercised, leaving 7,628,100 shares equivalent unexercised. - FY2024-Q3AdvancedAnnual report
「1 October 2023 to 31 December 2023 (Note 2): 24,600 shares; change in stated capital: ¥32 million; change in capital surplus: ¥32 million. (Note 2) Increase resulting from the exercise of stock acquisition rights.」
The exercise of performance-based stock acquisition rights resulted in the issuance of 24,600 shares, increasing stated capital and capital surplus by ¥32 million each. - FY2023-Q3AdvancedAnnual report
「As the likelihood of achieving the performance target underlying exercise of these stock acquisition rights increased, the Company recognized ¥5,568 million in expenses for stock acquisition rights and share-based compensation during the cumulative third-quarter consolidated accounting period.」
Following an increase in the likelihood of achieving the performance target for the performance-based stock acquisition rights, the Company recognized ¥5,568 million in expenses for stock acquisition rights and share-based compensation. - FY2021-Q1ReframedAnnual report
「In any fiscal year from the fiscal year ending March 2021 through the fiscal year ending March 2024, EBITDA of at least ¥15 billion In any fiscal year from the fiscal year ending March 2021 through the fiscal year ending March 2025, EBITDA of at least ¥20 billion In any fiscal year from the fiscal year ending March 2021 through the fiscal year ending March 2027, EBITDA of at least ¥30 billion」
Following the exercise of the previous performance-based stock acquisition rights, the Company granted 80,726 stock acquisition rights to 66 new eligible recipients, establishing multiple thresholds and periods for EBITDA achievement. - FY2018-Q2AchievedAnnual report
「1 July 2017 to 30 September 2017 (Note 2): 5,567,700 shares; change in stated capital: ¥186,517 thousand; change in capital surplus: ¥186,517 thousand. (Note 2) Increase resulting from the exercise of stock acquisition rights.」
The exercise of stock acquisition rights resulted in the issuance of 5,567,700 shares, increasing stated capital and capital surplus by ¥186,517 thousand each. The status of stock acquisition rights and other items was stated as “Not applicable.” - FY2018-Q1AdvancedAnnual report
「Between 1 July 2017 and 9 August 2017, the Company issued new shares upon the exercise of some of the stock acquisition rights resolved on 12 May 2016. The details were as follows: (1) Class of shares issued: common shares; (2) total shares issued: 5,519,286; (3) issue proceeds: ¥369,792 thousand; (4) amount of issue proceeds transferred to stated capital: ¥184,896 thousand; (5) stock acquisition rights exercised: 5,519,286; (6) stock acquisition rights remaining unexercised: 48,414.」
Of the performance-based stock acquisition rights, 5,519,286 were exercised and the same number of new shares was issued. The number remaining unexercised was 48,414. - FY2017-Q2First statedAnnual report
「The stock acquisition rights issued during the second quarter accounting period were as follows. Number of stock acquisition rights: 5,567,700. Exercise period: 1 July 2017 to 30 June 2020. The holders may exercise these stock acquisition rights only if, according to the audited consolidated income statement of the Company included in the securities report submitted for the fiscal year ended March 2017, operating income plus depreciation and goodwill amortization exceeds ¥3.3 billion.」
The Company issued 5,567,700 stock acquisition rights and introduced a performance-linked structure under which exercise was conditional on adjusted operating income for the fiscal year ended March 2017 exceeding ¥3.3 billion.